NEW YORK (GenomeWeb) – GenMark Diagnostics reported on Tuesday that it expects fourth quarter revenues of $14.9 million, up 13 percent year over year.

The company also reported preliminary full-year 2016 revenues of $49.2 million, up 25 percent compared to 2016.

The preliminary revenues just beat the average Wall Street estimate of $14.8 million for Q4 and $49.1 million for 2016.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.